CN105087817A - Method for detecting polymorphism of site rs2853669 of TERT human gene and kit - Google Patents

Method for detecting polymorphism of site rs2853669 of TERT human gene and kit Download PDF

Info

Publication number
CN105087817A
CN105087817A CN201510615764.6A CN201510615764A CN105087817A CN 105087817 A CN105087817 A CN 105087817A CN 201510615764 A CN201510615764 A CN 201510615764A CN 105087817 A CN105087817 A CN 105087817A
Authority
CN
China
Prior art keywords
fragment
cut
amplified production
site
restriction enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510615764.6A
Other languages
Chinese (zh)
Inventor
施学忠
杨永利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou University
Original Assignee
Zhengzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou University filed Critical Zhengzhou University
Priority to CN201510615764.6A priority Critical patent/CN105087817A/en
Publication of CN105087817A publication Critical patent/CN105087817A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a method for detecting the polymorphism of a site rs2853669 of a TERT human gene and a kit. The method includes the steps of providing to-be-detected human genome DNA; providing an upstream primer and a downstream primer for amplifying the sequence nearby the site rs2853669 of the TERT human gene, wherein the upstream primer comprises a mismatched base G; conducting a PCR amplification reaction through the upstream primer and the downstream primer with the to-be-detected human genome DNA as the template to obtain an amplification product with a fragment GGTYC or a fragment GACCGCGGTY, wherein Y represents an undetermined base C or T on the site rs2853669 of the TERT human gene; providing a restriction enzyme; conducting digestion on the obtained amplification product through the restriction enzyme to obtain a corresponding digestion product; determining whether the undetermined base Y on the site rs2853669 of the TERT human gene is C or T according to the obtained digestion product. The restriction enzyme can cut off one of the fragment GGTTC and the fragment GGTCC, or can cut off one of the fragment GACCGCGGTT and the fragment GACCGCGGTC. The detecting means is rapid and reliable, and the detecting cost is greatly reduced.

Description

People TERT gene rs2853669 loci polymorphism detection method and test kit
Technical field
The present invention relates to the method measuring single nucleotide polymorphism.
Background technology
SNP (single nucleotide polymorphism) refers to and comprises the forms such as the displacement of single base, insertion and disappearance by the mutant dna sequence that the change of single core thuja acid causes.Gene pleiomorphism is individual inherent hereditary feature, does not change with environment, neither the special or non-specific clinical manifestation of certain disease, and therefore its application does not exist Diagnosis and Treat effect.
Genetic polymorphism detection is widely used in genetic arts and medical field, is exemplified below: 1. study the genetics such as the origin of species and evolution phenomenon.According to genovariation situation, obtain the information of biomacromolecule, infer organic evolution history, illustrate spore relation.Be applied in archeology to determine the sibship of ancient human's heritable variation feature and different population.2. research polymorphic with population genetics etc. genetics research.Polymorphic also closely related with various characteristics of human body, comprise height, body weight, the colour of skin, Facial Features etc.3. may be used for prophylaxis in preventive medicine field.By the tolerance of researching human body to poisonous substance, find to be easy to, to the individuality of certain poisonous substance generation toxic action, avoid this individuality and toxicant exposure in time, protect this Susceptible population.Such as, carry out polymorphic detection to the crowd preparing to be engaged in the organic solvents such as Contact benzene, examination goes out easily to occur the individuality that hematotoxicity, neurotoxicity etc. are reacted, and makes it away from organic solvents such as benzene, protects this type of Susceptible population to encroach on from poisonous substance.4. may be used for medicament selection in pharmacology and dosage is determined.Can judge that diseased individuals is responsive to certain poisonous side effect of medicine by polymorphic detection, thus avoid using this kind of medicine to exempt its toxic action.By judging the individual level of response determination drug dose to effect of drugs, reduce drug dose and side effect thereof.
Telomere genes involved plays an important role in the integrity of protection telomere structure.TERT (Telomerasereversetranscriptase, TERT) is one of reversed transcriptive enzyme family member, has 7 conserved sequence structures to be reversed transcriptive enzyme functional domain, is a kind of special reversed transcriptive enzyme.The expression territory of TERT and telomerase activation are parallel relation, and TERT gene transcription level is considered to the main rate-limiting step of adjustable side telomerase activity, and telomerase activation can as one of diagnosing tumor index.TERT gene rs2853669 site is polymorphic, two kinds of allele C and T is there is in crowd, form the genotype of three kinds of TERT genes: CC type (two allelotrope bases of human genome rs2853669 polymorphic site are C), CT type (two allelotrope bases of human genome rs2853669 polymorphic site are respectively C and T) and TT type (two allelotrope bases of human genome rs10250202 polymorphic site are T).
Polymerase chain reaction-restriction fragment length polymorphic (PCR-RFLP) technology is a kind of quick, easy, accurate, low cost mensuration SNP (single nucleotide polymorphism) genotypic classical way.The method carries out amplified reaction by primer to template, forms sufficient amount and stable amplified production, by cutting and detect the fragment length of digestion products to the enzyme of amplified production, finally determines SNP.TERT gene rs2853669 polymorphic site can identify without restriction endonuclease, and PCR-RFLP technology can not be taked to detect, and needs to develop new detection technique.
Summary of the invention
The object of this invention is to provide the reliable means of the mensuration people TERT gene rs2853669 loci polymorphism of the diagnosis of a kind of non-diseases or therapeutic purpose.
According to a first aspect of the invention, provide a kind of method measuring people TERT gene rs2853669 loci polymorphism, comprising:
Human gene group DNA to be measured is provided;
There is provided upstream primer and the downstream primer of amplification people TERT gene rs2853669 location proximate sequence, wherein upstream primer has base mismatch G;
With described human gene group DNA to be measured for template, utilize upstream primer and downstream primer to carry out pcr amplification reaction to obtain the amplified production containing GGTYC fragment or GACCGCGGTY fragment, wherein Y is base C undetermined on people TERT gene rs2853669 site or T;
Restriction enzyme is provided;
Utilize restriction enzyme to carry out enzyme to gained amplified production and cut (reaction) to obtain corresponding digestion products; And
Determine that the base Y undetermined on people TERT gene rs2853669 site is C or T according to gained digestion products,
Wherein, restriction enzyme is the restriction enzyme that can cut one of GGTTC fragment and GGTCC fragment, maybe can cut the restriction enzyme of one of GACCGCGGTT fragment and GACCGCGGTC fragment.
According to embodiments of the invention, on gained amplified production, a base T of being separated by between base mismatch G and the Y of upstream primer.Surprisingly, so arrange base mismatch endonuclease reaction will be made to carry out extremely smooth, there will not be enzyme to cut the phenomenons such as insufficient.Further, so arrange downstream primer base mismatch and PCR reaction is well on, improve sensitivity and the specific degree of PCR, this may be relevant with making the secondary structural change of extension increasing sequence after base mismatch.
In a particular embodiment of the present invention, on gained amplified production, upstream primer terminal bases is adjacent with Y.Such as, upstream primer end can be ... the structures such as GGT.
In a preferred embodiment of the invention, restriction enzyme can adopt the AvaII or its isoschizomers that only can open and cut GGTCC fragment.This kind of AvaII enzyme is cheap, greatly can reduce cost of determination.
According to embodiments of the invention, gained digestion products comprises three kinds of clip types: have total fragment length do not cut off amplified production, cut off after have compared with the amplified production of long segment and after cutting off, there is amplified production (comparatively short-movie section can not effectively observe usually) compared with short-movie section.The clip types comprised by observation (judgement) digestion products determines that the base undetermined on people TERT gene rs2853669 site is C or T.Such as, when adopting AvaII enzyme, judge compared with the observations of these two fragments of long segment according to total fragment with after cutting off: if observe digestion products only have a kind of there is total fragment length do not cut off amplified production, then base undetermined is T; Only have one to have the cut-out product of comparatively long segment (being less than total fragment length) if observe digestion products, then base undetermined is C; If observe said two devices, then base undetermined not only comprises C but also comprise T.
In one embodiment of the invention, the clip types that judgement (or observation) digestion products comprises is schemed to contrast to carry out with reference after being taken pictures by gel electrophoresis associating ultraviolet lamp.In this case, preferably reference figure is that amplified production obtains and only has first with reference to picture position and second with reference to picture position after the gel electrophoresis standard setting time after ultraviolet lamp is taken pictures, wherein first with reference to picture position for be the amplified production of the total fragment length do not cut off, second with reference to picture position then for be cut off after there is amplified production compared with long segment.Such as, the present invention adopt with reference to figure be by 112bp and 70bp synthesized two base fragments simultaneously after gel electrophoresis same time ultraviolet lamp take pictures and form.Compared with the compound reference figure of conventional DNAladder, owing to have employed, only there are two specific reference figure with reference to picture position, this method of the present invention intuitively can be observed rapidly or judge the clip types that digestion products comprises, and avoids erroneous judgement to greatest extent simultaneously.After endonuclease reaction, preferably carry out electrophoresis by after concentrated for digestion products 1 ~ 2 times of concentration, increase brightness of image, improve judgment accuracy.
In a preferred embodiment of the invention, make total fragment length of amplified production between 100 to 300bp by designing the length of upstream primer and downstream primer, and the fragment length of upstream primer is at least 35bp, preferred length 40 ~ 60bp (amplified reaction especially smoothly fully between this dominant area), makes enzyme fall Partial Fragment length earnestly and accounts for the per-cent of total fragment length more than 20%.This design of the present invention has the electrophoresis ultraviolet photo of the amplified production compared with long segment position after can making to have not cutting off amplified production and cutting off of total fragment length is distinguished significantly.But if total fragment is long, then electrophoretic mobility shift is by not obvious; Too short, image can thicken a slice, cannot accurately distinguish.The fragment length scope of upstream primer ensure that pcr amplification reaction can carry out smoothly, the amplification that there will be when avoiding base mismatch not foot phenomenon.
In a preferred embodiment of the invention, by controlling the scope of annealing temperature in pcr amplification program between 55 ~ 70 DEG C, preferable temperature 60 ~ 69 DEG C (this temperature can improve the specificity of amplified reaction), make the PCR primer purity of design higher.This design of the present invention can make pcr amplification product band clear, occurs, be easy to electrophoresis identification without assorted band.But if temperature is too low, then few the and assorted band of specific band is too much, is difficult to after electrophoresis distinguish and judges; If temperature is too high, then affects pcr amplification efficiency and make specific amplified production very few, affect observing effect.
In a preferred embodiment of the invention, by controlling to extend the scope of time between 10 ~ 60s in pcr amplification program, preferred time 15 ~ 30s (this time can improve the efficiency of amplified reaction and the specificity of amplified production), make the PCR reaction times of design shorter, amplified production purity is higher.This design of the present invention can make pcr amplification product band clear, occurs, be easy to electrophoresis identification, and the PCR time is shorter without assorted band.But if the time is too short, then specific band can not increase completely and make amplified production less, be difficult to after electrophoresis distinguish judgement; If overlong time, then increase the occurrence probability of non-specific band, occur that assorted band affects observing effect.
In the present invention, PCR reacted constituent can comprise DNA profiling, upstream and downstream primer, TaqDNApolymerase (archaeal dna polymerase or also can be called " Taq enzyme "), damping fluid, Mg 2+deng.In a preferred embodiment of the invention, TaqDNApolymerase (archaeal dna polymerase) and TaqAntibody thereof can be used in pcr amplification reaction.TaqAntibody is the monoclonal antibody of TaqDNApolymerase, it suppresses DNA polymerase activity after being combined with TaqDNApolymerase, both avidity is very high, even if the activity of TaqDNApolymerase still can be closed at 65 DEG C, the non-specific amplification that therefore can effectively suppress the non-specific annealing of primer and primer dimer to cause, has high amplification sensitivity and specificity.ChampagneTaqAntibody only needs to get final product complete deactivation at 95 DEG C of heating 30s, and release TaqDNApolymerase is active, ensure that subsequent PCR amplification reaction can be carried out smoothly.
The Tris-HCl damping fluid that pH value is 8.1 ~ 8.7 can be added in PCR reaction, adjust PCR solution ph when 72 DEG C of extensions between 6.8 ~ 7.8, thus make Taq enzyme play activity better in slight alkali environment.In addition, gelatin (0.01%) can also be added in PCR solution to reduce the adsorption of PCR pipe to Taq enzyme, stabilized enzyme activity and provide protection, promote PCR reaction.
In addition, Mg in PCR solution 2+when concentration is between 1.5 ~ 2.0mmol/L, can well control PCR react productive rate and specificity.
The final concentration that PCR reacts primer is generally about 0.1 ~ 1 μM, and the too high meeting of concentration causes non-specific amplification, and too low then amplified production very little.
In addition, can also add solubility promoter methyl-sulphoxide (DMSO) and ammonium sulfate to reduce base mispairing level in PCR reaction, the amplification efficiency of GC template is rich in raising.This with the secondary structure eliminating primer and template, may reduce DNA melting temperature(Tm) and makes DNA sex change completely relevant.
According to a further aspect in the invention, provide a kind of test kit for measuring people TERT gene rs2853669 loci polymorphism, it comprises:
For upstream primer and the downstream primer of pcr amplification people TERT gene rs2853669 location proximate sequence, wherein upstream primer has base mismatch G to obtain the amplified production containing GGTYC fragment or GACCGCGGTY fragment, and wherein Y is base C undetermined on people TERT gene rs2853669 site or T; And
The restriction enzyme of one of GGTTC fragment and GGTCC fragment can be cut, maybe can cut the restriction enzyme of one of GACCGCGGTT fragment and GACCGCGGTC fragment.
Can also comprise other composition in mentioned reagent box, such as PCR reacts Mix and (mainly comprises dNTPs, Mg 2+, TaqDNApolymerase, TaqAntibody etc.) and for implementing the specification sheets etc. measured.
It will be understood by those skilled in the art that unless there are obvious conflict, the correlated characteristic of a first aspect of the present invention and second aspect can combine mutually.
Mensuration means of the present invention are not only fast and reliable, and cost of determination reduces greatly.
Accompanying drawing explanation
Fig. 1 describes the digestion products electrophoresis ultraviolet photo that method according to the present invention obtains.Wherein Marker is: standard reference position; Swimming lane 1:CC type test result; Swimming lane 2:CT mixed type test result; Swimming lane 3:TT type test result.
Embodiment
Describe the present invention below.It will be appreciated by those skilled in the art that following detailed description only for illustration of and non-limiting the present invention.
(1) acquisition of DNA to be measured
Gather different crowd peripheral blood, after extracting genomic dna, carry out the mensuration of TERT gene rs2853669 loci polymorphism below.
For the selection of DNA to be measured, the not special restriction of the present invention.Both can be obtain in vitro sample from the body fluid of human body or tissue, the genome of degradation treatment in advance can also be through.For convenience of implementation, usually preferably in vitro sample is extracted from blood.Wherein said tissue comprises the tissue containing all or at least TERT gene in human body, and with whether express this TERT gene and have nothing to do.The method extracting DNA from body fluid and/or tissue well known to a person skilled in the art, and can with reference to conventional molecular biology manual, and such as " molecular cloning " the 2nd edition carries out.
(2) design of primers and synthesis
Search Gene database and the snp database of NCBI website, obtain TERT gene complete sequence and rs2853669 polymorphic site information respectively.
Rs2853669 polymorphic site Y front and rear part base sequence (base sequence represents with 5' → 3', capital and small letter same meaning) following (SEQIDNO:1):
Carry out upstream primer and downstream primer design according to gene order, wherein, upstream primer introduces base mismatch.On final gained amplified production, a base T of being separated by between base mismatch G and the Y of upstream primer
In the present invention, upstream primer has base mismatch G, and length is 35 ~ 60bp.In one of them embodiment, primer is as follows, upstream primer: 5'GGGCTCCCAGTGGATTCGCGGGCACAGACGCCCAGTACCGCG gt3'(SEQIDNO:2), downstream primer: 5'GGAGGCGGAGCTGGAAGGTGAAGGGGCAGGACGGGTGCCCGGTTCCCC (SEQIDNO:3), wherein upstream primer underscore base is base mismatch.
(3) pcr amplification product is prepared
Formulate pcr amplification program and condition according to upstream primer and downstream primer feature and PCR corresponding reagent, prepare pcr amplification product.In one of them embodiment, get genomic dna (50 ~ 80ng), upstream and downstream primer (final concentration is 0.1 ~ 1 μM), 2 × PCRMix7.5 μ L (comprise 4 kinds of dNTP mixtures, TaqDNApolymerase, TaqAntibody, Mg 2+, damping fluid, DMSO and ammonium sulfate) and distilled water jointly form 15 μ L reaction systems, adjustment pH value of solution be about 7.3.PCR reaction conditions is: 95 DEG C of denaturation 30s, and DEG C annealing 30s → 72 DEG C, 95 DEG C of sex change 30s → 65 extend 20s totally 30 circulations, and 72 DEG C extend 7min.Stable amplified production is obtained after PCR reaction.
(4) endonuclease reaction
The present invention can adopt AvaII restriction endonuclease, Sau96I restriction endonuclease, PshAI restriction endonuclease, and the polymorphic qualification for TERT gene rs2853669 site provides the restriction endonuclease that plurality of optional is selected, and can select suitable restriction endonuclease during experiment according to market value.Current part restriction endonuclease less expensive, as shown in table 1.
Table several endonuclease recognition sequence of 1NEB company and price thereof
Note: W is A or T; N is A or C or T or G.
In one of them embodiment, get PCR primer 10 μ L, add 5U restriction endonuclease AvaII, 2 μ L10 × enzyme cutting buffering liquids and 7.5 μ L distilled waters and form 20 μ L reaction systems, in 37 DEG C of water-baths, enzyme cuts 4 ~ 12h, obtain digestion products, digestion products is observed through 1 times of concentrated rear electrophoresis.
(5) electrophoresis test
In one of them embodiment, if PCR primer can not be cut after AvaII enzyme is cut, be still 112bp, if be cut open, occur that (cut generation sticky end due to AvaII enzyme makes its complementary strand bases number different to 70bp with 42bp, therefore after cutting, fragment length is as the criterion with strand base number in gene order and calculates), be wherein difficult in 42bp fragment electrophoretic figure differentiate.
By digestion products in 2 ~ 4% sepharoses under 3 ~-8V/cm condition, electrophoresis 30-80min, mensuration of taking pictures under ultraviolet lamp.Restriction enzyme digestion and electrophoresis is shown in Fig. 1, and the presence or absence according to 112bp and 70bp fragment judges genotype: TT type is 112bp fragment, and CT type has 112bp, 70bp fragment, and CC type is 70bp fragment.
Here implements some embodiments of the present invention.
Embodiment 1 is extracted human peripheral leucocytes DNA and is measured rs2853669 polymorphism
1 materials and methods
1.1 main agents and instrument
Reagent: 2 × PCRMix (comprises 4 kinds of dNTP mixtures, TaqDNApolymerase, TaqAntibody, Mg 2+, damping fluid, DMSO and ammonium sulfate), restriction enzyme A vaII (NEB company), agarose (Biowest company), primer is synthesized by Shanghai Sangon company.
Instrument: 9600 type PCR instrument (PE company), miniature electrophoresis chamber (PharmaciaBiotech, EPS1000), GelDoc2000 gel imaging instrument (Bio-RAD company).
1.2 extract DNA as testing gene group DNA profiling from peripheral blood leucocyte
EDTA-K 2anticoagulant tube gathers human peripheral 1mL, white corpuscle separation is carried out with reference to leukocytic separation method in " practical flow cytometry icones ", white corpuscle genomic dna is extracted with reference to NaCl salting-out method in " molecular cloning ", and as human gene group DNA's template to be measured.
1.3 sequences are searched and design of primers
TERT gene order and rs2853669 polymorphic site information is searched to design primer in NCBI website, specific as follows:
Upstream primer: 5'GGGCTCCCAGTGGATTCGCGGGCACAGACGCCCAGTACCGCG gt3'(SEQIDNO:2);
Downstream primer: 5'GGAGGCGGAGCTGGAAGGTGAAGGGGCAGGACGGGTGCCCGGTTCCCC3'(SEQ IDNO:3)
1.4PCR amplification
Get genomic dna (50 ~ 80ng), upstream and downstream primer (final concentration is 0.1 ~ 1 μM), 2 × PCRMix7.5 μ L (comprise 4 kinds of dNTP mixtures, TaqDNApolymerase, TaqAntibody, Mg 2+, damping fluid, DMSO and ammonium sulfate), sterilizing distilled water supplies 15 μ L reaction systems, adjustment pH value of solution be about 7.3.
PCR reaction conditions is: 95 DEG C of denaturation 30s, and DEG C annealing 30s → 72 DEG C, 95 DEG C of sex change 30s → 65 extend 20s totally 30 circulations, and 72 DEG C extend 7min.Stable amplified production is obtained after PCR reaction.
1.5 enzymes cut qualification
After pcr amplification, get PCR primer 10 μ l, add 5U restriction endonuclease AvaII, 2 μ l10 × enzyme cutting buffering liquids and sterilizing distilled water and form 20 μ l reaction systems, in 37 DEG C of water-baths, enzyme cuts 4h, obtains digestion products.
After above-mentioned digestion products is concentrated through 1 times, under 3% sepharose 5V/cm condition, electrophoresis 40min, qualification Polymorphic type of taking pictures under ultraviolet lamp.
2 results
2.1PCR amplification
Sequence (it is arranged in SEQIDNO:1 base sequence 257-368 place, altogether 112bp) after amplification, the amplified production sequence obtained following (SEQIDNO:4):
In amplification after product sequence, underscore part is respectively the sequence corresponding to upstream, downstream primer, and Y represents the polymorphic i.e. SNP site rs2853669 of C/T.
2.2 enzymes cut result
Product Sequence after AvaII enzyme is cut is as follows respectively:
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 70bp (this fragment downstream sequence forms sticky end because enzyme is cut and reduces by 3 bases than upstream sequence) sequence (SEQIDNO:5):
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 42bp (this fragment downstream sequence forms sticky end because enzyme is cut and increases by 3 bases than upstream sequence) sequence (SEQIDNO:6):
gggctcccagtggattcgcgggcacagacgcccagtaccgcg42
Take pictures under ultraviolet lamp after digestion products electrophoresis qualification, result is shown in Figure 1.Wherein, there is 112bp segment after the amplification of rs2853669 site.There are 112bp, 70bp, 42bp tri-kinds of fragments (wherein 42bp not easily differentiates in electrophorogram) after AvaII enzyme is cut.
Enzyme is cut rear genotype and is judged: CC type is 70bp fragment, and CT type has 112bp and 70bp two kinds of fragments, and TT type is 112bp fragment.
The polymorphic result in 2.3TERT gene rs2853669 site
Detect 18 routine personnel altogether, detected result finds that CC type 8 example, CT type 6 example and TT type 4 example appear in rs2853669 site.
Embodiment 2 human peripheral whole blood sample measures rs2853669 polymorphism
Main agents is except restriction endonuclease is Sau96I, and all the other are with embodiment 1; Instrument is with embodiment 1.Peripheral blood genomic dna is extracted with reference to phenol-chloroform extraction process in " molecule clone technology ", and as human gene group DNA's template to be measured.
Sequence searches same embodiment 1, and design primer sequence is as follows:
Upstream primer: 5'GCTCCCAGTGGATTCGCGGGCACAGACGCCCAAGACCGCG gt3'(SEQIDNO:7);
Downstream primer: 5'GGAGCTGGAAGGTGAAGGGGCAGGACGGGTGCCCGGTTCCCC3'(SEQIDNO:8)
Get genomic dna (50 ~ 80ng), upstream and downstream primer (final concentration is 0.1 ~ 1 μM), 2 × PCRMix10 μ L (comprise 4 kinds of dNTP mixtures, TaqDNApolymerase, TaqAntibody, Mg 2+, damping fluid, DMSO and ammonium sulfate), sterilizing distilled water supplies 20 μ l reaction systems, adjustment pH value of solution be about 7.3.
It is 63 DEG C that PCR reaction conditions removes annealing temperature, and all the other conditions are with embodiment 1.
Enzyme cuts qualification: get PCR primer 10 μ l, and add 5U restriction endonuclease Sau96I, 2 μ l10 × enzyme cutting buffering liquids and sterilizing distilled water and form 20 μ l reaction systems, in 37 DEG C of water-baths, enzyme cuts 4h, obtains digestion products.
After digestion products is concentrated through 1 times, under 2.5% sepharose 5V/cm condition, electrophoresis 35min, qualification of taking pictures under ultraviolet lamp.
Result
Pcr amplification result
Sequence (it is arranged in SEQIDNO:1 base sequence 259-362 place, altogether 104bp) after amplification, the amplified production sequence obtained following (SEQIDNO:9):
In amplification after product sequence underscore part be upstream, sequence corresponding to downstream primer, Y represents the polymorphic i.e. SNP site rs2853669 of C/T.
Enzyme cuts result
Product Sequence after Sau96I enzyme is cut is as follows respectively:
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 64bp (this fragment downstream sequence forms sticky end because enzyme is cut and reduces by 3 bases than upstream sequence) sequence (SEQIDNO:10):
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 40bp (this fragment downstream sequence forms sticky end because enzyme is cut and increases by 3 bases than upstream sequence) sequence (SEQIDNO:11):
gctcccagtggattcgcgggcacagacgcccaagaccgcg40
After Sau96I enzyme is cut, genotype judges same embodiment 1.Detect 16 routine personnel altogether, detected result finds that CC type 7 example, CT type 3 example and TT type 6 example appear in rs2853669 site.
Embodiment 3 human peripheral blood clot sample measures rs2853669 polymorphism
Main agents is except restriction endonuclease is PshAI, and all the other are with embodiment 1; Instrument is with embodiment 1.Blood clot genomic dna is extracted with reference to phenol-chloroform extraction process in " molecule clone technology ".
It is SEQNO:11 that PCR reacts the upstream primer adopted, and downstream primer is SEQNO:12.
Upstream primer: 5'GGGCTCCCAGTGGATTCGCGGGCACAGACGCCCAGGACCGCG gt3'(SEQIDNO:12);
Downstream primer: 5'GGAAGGGGAGGGGCTGGGA3'(SEQIDNO:13)
Pcr amplification is except annealing temperature is 66 DEG C, and remaining reaction condition is with embodiment 1.
Enzyme cuts qualification: get PCR primer 10 μ l, and add 5U restriction endonuclease PshAI, 2 μ l10 × enzyme cutting buffering liquids and sterilizing distilled water and form 20 μ l reaction systems, in 37 DEG C of water-baths, enzyme cuts 4h, obtains digestion products.
After above-mentioned digestion products is concentrated through 1 times, under 2.5% sepharose 5V/cm condition, electrophoresis 35min, qualification of taking pictures under ultraviolet lamp.
Result:
Sequence (it is arranged in SEQIDNO:1 base sequence 257-450 place, altogether 194bp) after amplification, the amplified production sequence obtained following (SEQIDNO:14):
In Product Sequence underscore part be upstream, sequence corresponding to downstream primer, Y represents the polymorphic i.e. SNP site rs2853669 of C/T.
Enzyme cut after Product Sequence respectively as follows:
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 154bp sequence (SEQIDNO:15):
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 40bp sequence (SEQIDNO:16):
gggctcccagtggattcgcgggcacagacgcccaggaccg40
Take pictures under ultraviolet lamp after digestion products electrophoresis qualification, result is shown in Figure 1.Wherein, there is 194bp segment after the amplification of rs2853669 site.There are 194bp, 154bp, 40bp tri-kinds of segments (wherein 40bp not easily differentiates in electrophorogram) after PshAI enzyme is cut.
Enzyme is cut rear genotype and is judged: CC type is 154bp fragment, and CT type has 194bp and 154bp two kinds of fragments, and TT type is 194bp fragment.
Polymorphic result: detect 11 routine personnel altogether, detected result finds that CC type 4 example, CT type 3 example and TT type 4 example appear in rs2853669 site.
Embodiment 4 human lung tissue sample measures TERT gene rs2853669 polymorphism
Phenol-chloroform extraction process is adopted to carry out lung tissue block genome DNA extraction.
It is SEQNO:1 that PCR reacts the upstream primer adopted, and downstream primer is SEQNO:14.
Upstream primer: 5'CGGGCTCCCAGTGGATTCGCGGGCACAGACGCCCAGGACCGCG gt3'(SEQIDNO:17);
Downstream primer: 5'GGAAAGGAAGGGGAGGGGCTGGGA3'(SEQIDNO:18)
Pcr amplification is except annealing temperature is 68 DEG C, and remaining reaction condition is with embodiment 1;
Enzyme cuts qualification with embodiment 3.
Result:
Sequence (it is arranged in SEQIDNO:1 base sequence 256-455 place, altogether 200bp) after amplification, the amplified production sequence obtained following (SEQIDNO:19):
In amplification after product sequence underscore part be upstream, sequence corresponding to downstream primer, Y represents the polymorphic i.e. SNP site rs2853669 of C/T.
Enzyme cut after Product Sequence respectively as follows:
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 159bp sequence (SEQIDNO:20):
When this polymorphic site contains C allelotrope, PCR primer enzyme can be formed after cutting and cut fragment 41bp sequence (SEQIDNO:21):
cgggctcccagtggattcgcgggcacagacgcccaggaccg41
Take pictures under ultraviolet lamp after digestion products electrophoresis qualification, result is shown in Figure 1.Wherein, there is 200bp segment after the amplification of rs2853669 site.200bp, 159bp, 41bp (wherein 41bp not easily differentiates in electrophorogram) is there is after PshAI enzyme is cut.
Enzyme is cut rear genotype and is judged: CC type is 159bp fragment, and CT type has 200bp and 159bp two kinds of fragments, and TT type is 200bp fragment.
Polymorphic result: detect 12 routine personnel altogether, detected result finds that CC type 2 example, CT type 6 example and TT type 4 example appear in rs2853669 site.

Claims (10)

1. measure a method for people TERT gene rs2853669 loci polymorphism, comprising:
Human gene group DNA to be measured is provided;
There is provided upstream primer and the downstream primer of amplification people TERT gene rs2853669 location proximate sequence, wherein upstream primer has base mismatch G;
With described human gene group DNA to be measured for template, utilize upstream primer and downstream primer to carry out pcr amplification reaction to obtain the amplified production containing GGTYC fragment or GACCGCGGTY fragment, wherein Y is base C undetermined on people TERT gene rs2853669 site or T;
Restriction enzyme is provided;
Utilize restriction enzyme to carry out enzyme to gained amplified production to cut to obtain corresponding digestion products;
And determine that the base Y undetermined on people TERT gene rs2853669 site is C or T according to gained digestion products,
Wherein, restriction enzyme is the restriction enzyme that can cut one of GGTTC fragment and GGTCC fragment, maybe can cut the restriction enzyme of one of GACCGCGGTT fragment and GACCGCGGTC fragment.
2. method according to claim 1, wherein on gained amplified production, a base T of being separated by between base mismatch G and the Y of upstream primer.
3. method according to claim 2, wherein on gained amplified production, upstream primer terminal bases is adjacent with Y.
4. method according to claim 1, wherein restriction enzyme is AvaII, Sau96I or its isoschizomers that can cut GGTCC fragment.
5. method according to claim 1, wherein restriction enzyme is PshAI or its isoschizomers that can cut GACCGCGGTC fragment.
6. method according to claim 1, wherein gained digestion products comprises three kinds of clip types: have total fragment length do not cut off amplified production, cut off after have compared with the amplified production of long segment and after cutting off, there is amplified production compared with short-movie section, by judging that the clip types that digestion products comprises determines that the base Y undetermined on people TERT gene rs2853669 site is C or T.
7. method according to claim 6, wherein judge clip types that digestion products comprises taken pictures by gel electrophoresis associating ultraviolet lamp after with reference to scheming to contrast to carry out.
8. method according to claim 7, wherein reference figure is that amplified production obtains and only has first with reference to picture position and second with reference to picture position after the gel electrophoresis standard setting time after ultraviolet lamp is taken pictures, wherein first with reference to picture position for be the amplified production of the total fragment length do not cut off, second with reference to picture position then for be cut off after there is amplified production compared with long segment.
9. method according to claim 1, wherein make total fragment length of amplified production between 100 to 300bp by designing the length of upstream primer and downstream primer, and the fragment length of upstream primer is at least 35bp, makes enzyme fall Partial Fragment earnestly and account for the per-cent of the length of total fragment more than 20%.
10., for measuring a test kit for people TERT gene rs2853669 loci polymorphism, it comprises:
For upstream primer and the downstream primer of pcr amplification people TERT gene rs2853669 location proximate sequence, wherein upstream primer has base mismatch G to obtain the amplified production containing GGTYC fragment or GACCGCGGTY fragment, and wherein Y is base C undetermined on people TERT gene rs2853669 site or T; And
The restriction enzyme of one of GGTTC fragment and GGTCC fragment can be cut, maybe can cut the restriction enzyme of one of GACCGCGGTT fragment and GACCGCGGTC fragment.
CN201510615764.6A 2015-09-24 2015-09-24 Method for detecting polymorphism of site rs2853669 of TERT human gene and kit Pending CN105087817A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510615764.6A CN105087817A (en) 2015-09-24 2015-09-24 Method for detecting polymorphism of site rs2853669 of TERT human gene and kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510615764.6A CN105087817A (en) 2015-09-24 2015-09-24 Method for detecting polymorphism of site rs2853669 of TERT human gene and kit

Publications (1)

Publication Number Publication Date
CN105087817A true CN105087817A (en) 2015-11-25

Family

ID=54569141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510615764.6A Pending CN105087817A (en) 2015-09-24 2015-09-24 Method for detecting polymorphism of site rs2853669 of TERT human gene and kit

Country Status (1)

Country Link
CN (1) CN105087817A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103923976A (en) * 2014-01-28 2014-07-16 吴松 Method for detecting single nueleotide polymorphism of TERT
CN104404128A (en) * 2014-02-18 2015-03-11 广州金域医学检验中心有限公司 TERT gene combination mutation site detection kit
WO2015049063A1 (en) * 2013-10-02 2015-04-09 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Human tert promoter variants, as well as kits, methods and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015049063A1 (en) * 2013-10-02 2015-04-09 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Human tert promoter variants, as well as kits, methods and uses thereof
CN103923976A (en) * 2014-01-28 2014-07-16 吴松 Method for detecting single nueleotide polymorphism of TERT
CN104404128A (en) * 2014-02-18 2015-03-11 广州金域医学检验中心有限公司 TERT gene combination mutation site detection kit

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《TUMOUR BIOLOGY》 *
《遗传》 *
JING LIU,ET AL: "An improved allele-specific PCR primer design method for SNP marker analysis and its application", 《PLANT METHODS》 *

Similar Documents

Publication Publication Date Title
CN102586408B (en) The detection method of hypertension susceptible gene Mfn2 mononucleotide polymorphism site rs3820189 and detection kit
JP5818018B2 (en) Circular primer using nucleic acid amplification and its application
Eamsobhana et al. Molecular differentiation and phylogenetic relationships of three Angiostrongylus species and Angiostrongylus cantonensis geographical isolates based on a 66-kDa protein gene of A. cantonensis (Nematoda: Angiostrongylidae)
CN105274212A (en) Method and kit for determination of human POT1 gene rs1034794 site polymorphism
CN105274204A (en) Method and kit for determination of human PLIN1 gene rs894160 site polymorphism
Lorenz et al. Morphogenetic characterisation, date of divergence, and evolutionary relationships of malaria vectors Anopheles cruzii and Anopheles homunculus
CN105274213A (en) Method and kit for determination of human PLIN1 gene rs894160 site polymorphism
CN105256008A (en) Method and kit used for determining human PON1 gene rs662 site polymorphism
JP2010068797A (en) Method for distinguishing biotype in bemisia tabaci
CN105256006A (en) Method and kit used for determining human TERF1 gene rs201882345 site polymorphism
CN105087817A (en) Method for detecting polymorphism of site rs2853669 of TERT human gene and kit
CN110499368A (en) One kind SNP marker relevant to carcinoma of mouth prognosis prediction and its application
CN105331682A (en) Human PON1 gene rs854560 site polymorphism detection method and kit
CN105274215A (en) Method and kit for determining rs854560 site polymorphism of PON1 gene
CN105256005A (en) Method and kit used for determining human TERT gene rs2735940 site polymorphism
CN105274206A (en) Method and kit for determination of human TERT gene rs2853669 site polymorphism
CN105063234A (en) Human TERT gene rs2853669-locus polymorphism investigation technology
CN105087818A (en) Method and kit for determining POT1 gene rs1034794 locus polymorphism
CN105274210A (en) Method and kit for determination of human PLIN1 gene rs2289487site polymorphism
CN105274208A (en) Technology for determination of human PLIN1 gene rs2289487 site polymorphism
CN105274217A (en) Method and kit for determining rs3093816 site polymorphism of human CCNH gene
CN105274216A (en) Method and kit for determining rs2979704 site polymorphism of human NEFL gene
CN105316406A (en) Method and kit for measuring human NEFM gene rs12515 site polymorphism
CN105274207A (en) Method and kit for determination of human CDKN1B gene rs34329 site polymorphism
CN105256011A (en) Method and kit used for determining human POT1 gene rs10250202 site polymorphism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20151125

RJ01 Rejection of invention patent application after publication